Skip to main content
Erschienen in: Journal of Mammary Gland Biology and Neoplasia 4/2009

01.12.2009

Hormone-Responsive Model of Primary Human Breast Epithelium

verfasst von: J. Dinny Graham, Patricia A. Mote, Usha Salagame, Rosemary L. Balleine, Lily I. Huschtscha, Christine L. Clarke

Erschienen in: Journal of Mammary Gland Biology and Neoplasia | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Retention of hormone responsiveness in primary culture models of human breast is essential for studies aimed at understanding the mechanisms of action of the ovarian hormones in the human breast. In this chapter we describe the development of a culture model of primary human breast that retains critical features of the tissue in vivo. We find that primary normal human breast tissue in embedded culture recapitulates the morphology, cell lineages, functional gene expression characteristics and estrogen and progesterone receptor responsiveness of the breast in vivo. The ratio of luminal to myoepithelial cells after culture recapitulates that observed in the uncultured tissue, highlighting the fact that progenitor cells capable of giving rise to both epithelial cell lineages are retained in this model system. By contrast, primary cells placed into monolayer culture, even for a single passage, lose bipotent progenitors, and the myoepithelial lineage predominates, demonstrating the rapidity with which phenotypic changes and selection occur in normal breast cells, unless cultured under conditions that prevent this outcome. Primary matrix-embedded culture of normal human breast cells provides researchers with a new opportunity to understand ovarian hormone action in the human breast.
Literatur
1.
Zurück zum Zitat Howard BA, Gusterson BA. Human breast development. J Mammary Gland Biology Neoplasia. 2000;5:119–37.CrossRef Howard BA, Gusterson BA. Human breast development. J Mammary Gland Biology Neoplasia. 2000;5:119–37.CrossRef
2.
Zurück zum Zitat Ismail PM, Amato P, Soyal SM, et al. Progesterone involvement in breast development and tumorigenesis–as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids. 2003;68(10–13):779–87.CrossRefPubMed Ismail PM, Amato P, Soyal SM, et al. Progesterone involvement in breast development and tumorigenesis–as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids. 2003;68(10–13):779–87.CrossRefPubMed
3.
Zurück zum Zitat Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20(3):358–417.CrossRefPubMed Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20(3):358–417.CrossRefPubMed
4.
Zurück zum Zitat Santen RJ. Risk of breast cancer with progestins: critical assessment of current data. Steroids. 2003;68(10–13):953–64.CrossRefPubMed Santen RJ. Risk of breast cancer with progestins: critical assessment of current data. Steroids. 2003;68(10–13):953–64.CrossRefPubMed
5.
Zurück zum Zitat Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biology Neoplasia. 1998;3:23–35.CrossRef Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biology Neoplasia. 1998;3:23–35.CrossRef
6.
Zurück zum Zitat Lakhani SR, O’Hare MJ. The mammary myoepithelial cell—Cinderella or ugly sister? Breast Cancer Res. 2001;3:1–4.CrossRefPubMed Lakhani SR, O’Hare MJ. The mammary myoepithelial cell—Cinderella or ugly sister? Breast Cancer Res. 2001;3:1–4.CrossRefPubMed
7.
Zurück zum Zitat Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36(Suppl 1):59–72.CrossRefPubMed Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36(Suppl 1):59–72.CrossRefPubMed
8.
Zurück zum Zitat Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115(Pt 1):39–50.PubMed Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115(Pt 1):39–50.PubMed
9.
Zurück zum Zitat Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002;4(5):197–201.CrossRefPubMed Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002;4(5):197–201.CrossRefPubMed
10.
Zurück zum Zitat Nelson CM, Bissell MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol. 2005;15(5):342–52.CrossRefPubMed Nelson CM, Bissell MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol. 2005;15(5):342–52.CrossRefPubMed
11.
Zurück zum Zitat Humason G. Animal tissue techniques. 4th ed. San Francisco: WH Freeman & Co; 1979. Humason G. Animal tissue techniques. 4th ed. San Francisco: WH Freeman & Co; 1979.
12.
Zurück zum Zitat Rosen PP. Breast pathology. Philadelphia: Lippincott-Raven; 1997. Rosen PP. Breast pathology. Philadelphia: Lippincott-Raven; 1997.
13.
Zurück zum Zitat Graham JD, Mote PA, Salagame U, et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009;150(7):3318–26.CrossRefPubMed Graham JD, Mote PA, Salagame U, et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009;150(7):3318–26.CrossRefPubMed
14.
Zurück zum Zitat Mote PA, Bartow S, Tran N, Clarke CL. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002;72(2):163–72.CrossRefPubMed Mote PA, Bartow S, Tran N, Clarke CL. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002;72(2):163–72.CrossRefPubMed
15.
Zurück zum Zitat Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35.PubMed Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35.PubMed
16.
Zurück zum Zitat Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.CrossRefPubMed Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.CrossRefPubMed
Metadaten
Titel
Hormone-Responsive Model of Primary Human Breast Epithelium
verfasst von
J. Dinny Graham
Patricia A. Mote
Usha Salagame
Rosemary L. Balleine
Lily I. Huschtscha
Christine L. Clarke
Publikationsdatum
01.12.2009
Verlag
Springer US
Erschienen in
Journal of Mammary Gland Biology and Neoplasia / Ausgabe 4/2009
Print ISSN: 1083-3021
Elektronische ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-009-9160-6

Weitere Artikel der Ausgabe 4/2009

Journal of Mammary Gland Biology and Neoplasia 4/2009 Zur Ausgabe

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.